CZ289304B6 - Farmaceutický prostředek ve formě efervescentních práąků nebo tablet, farmaceutický přípravek a způsob přípravy tohoto přípravku - Google Patents
Farmaceutický prostředek ve formě efervescentních práąků nebo tablet, farmaceutický přípravek a způsob přípravy tohoto přípravku Download PDFInfo
- Publication number
- CZ289304B6 CZ289304B6 CZ19951419A CZ141995A CZ289304B6 CZ 289304 B6 CZ289304 B6 CZ 289304B6 CZ 19951419 A CZ19951419 A CZ 19951419A CZ 141995 A CZ141995 A CZ 141995A CZ 289304 B6 CZ289304 B6 CZ 289304B6
- Authority
- CZ
- Czechia
- Prior art keywords
- parts
- weight
- ibuprofen
- pharmaceutically acceptable
- effervescent
- Prior art date
Links
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 21
- 239000007911 effervescent powder Substances 0.000 title claims abstract description 17
- 239000000825 pharmaceutical preparation Substances 0.000 title claims abstract 6
- 238000002360 preparation method Methods 0.000 title claims description 14
- 238000004519 manufacturing process Methods 0.000 title abstract description 4
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims abstract description 65
- 229960001680 ibuprofen Drugs 0.000 claims abstract description 62
- 239000000203 mixture Substances 0.000 claims abstract description 35
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 27
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 24
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 24
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims abstract description 21
- 150000008041 alkali metal carbonates Chemical group 0.000 claims abstract description 21
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 239000003826 tablet Substances 0.000 claims abstract description 15
- 239000004615 ingredient Substances 0.000 claims abstract description 13
- 150000007524 organic acids Chemical class 0.000 claims abstract description 13
- 239000000654 additive Substances 0.000 claims abstract description 7
- 230000000996 additive effect Effects 0.000 claims abstract description 6
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 6
- 239000003765 sweetening agent Substances 0.000 claims abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 42
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 35
- 235000006708 antioxidants Nutrition 0.000 claims description 23
- 239000003085 diluting agent Substances 0.000 claims description 19
- 239000004337 magnesium citrate Substances 0.000 claims description 19
- 229960005336 magnesium citrate Drugs 0.000 claims description 19
- 235000002538 magnesium citrate Nutrition 0.000 claims description 19
- 229940087168 alpha tocopherol Drugs 0.000 claims description 18
- 229960000984 tocofersolan Drugs 0.000 claims description 18
- 239000002076 α-tocopherol Substances 0.000 claims description 18
- 235000004835 α-tocopherol Nutrition 0.000 claims description 18
- 239000012024 dehydrating agents Substances 0.000 claims description 17
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical group [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims description 17
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 13
- 239000008101 lactose Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 8
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 6
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 claims description 6
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 5
- 239000003086 colorant Substances 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 159000000007 calcium salts Chemical class 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 claims description 3
- RPWFJAMTCNSJKK-UHFFFAOYSA-N Dodecyl gallate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 RPWFJAMTCNSJKK-UHFFFAOYSA-N 0.000 claims description 3
- 239000002211 L-ascorbic acid Substances 0.000 claims description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- -1 butyl hydroxy toluene oxalate Chemical compound 0.000 claims description 3
- 235000010389 delta-tocopherol Nutrition 0.000 claims description 3
- 239000000555 dodecyl gallate Substances 0.000 claims description 3
- 235000010386 dodecyl gallate Nutrition 0.000 claims description 3
- 229940080643 dodecyl gallate Drugs 0.000 claims description 3
- 235000010382 gamma-tocopherol Nutrition 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000574 octyl gallate Substances 0.000 claims description 3
- 235000010387 octyl gallate Nutrition 0.000 claims description 3
- NRPKURNSADTHLJ-UHFFFAOYSA-N octyl gallate Chemical compound CCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 NRPKURNSADTHLJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000473 propyl gallate Substances 0.000 claims description 3
- 235000010388 propyl gallate Nutrition 0.000 claims description 3
- 229940075579 propyl gallate Drugs 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 235000010384 tocopherol Nutrition 0.000 claims description 3
- 239000002478 γ-tocopherol Substances 0.000 claims description 3
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 claims description 3
- 239000002446 δ-tocopherol Substances 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- VAUIYOPXEJWUFG-UHFFFAOYSA-N C(CCCCCCCCCCCCCCC)C1(C(=C(C(=O)O1)O)O)C(O)CO Chemical compound C(CCCCCCCCCCCCCCC)C1(C(=C(C(=O)O1)O)O)C(O)CO VAUIYOPXEJWUFG-UHFFFAOYSA-N 0.000 claims 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 abstract description 2
- 238000011105 stabilization Methods 0.000 abstract description 2
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 19
- 235000015165 citric acid Nutrition 0.000 description 12
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 description 10
- 238000005469 granulation Methods 0.000 description 6
- 230000003179 granulation Effects 0.000 description 6
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 5
- 229940085605 saccharin sodium Drugs 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000008119 colloidal silica Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000007916 tablet composition Substances 0.000 description 2
- LTSFKYMMVSEWPP-BVFKYQGHSA-N (2r,3r,4r,5r)-hexane-1,2,3,4,5,6-hexol;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O LTSFKYMMVSEWPP-BVFKYQGHSA-N 0.000 description 1
- FRLGFEJDRMTGHL-YFKPBYRVSA-N (2s)-6-amino-2-(carboxyamino)hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)NC(O)=O FRLGFEJDRMTGHL-YFKPBYRVSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010043521 Throat irritation Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940001593 sodium carbonate Drugs 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- NKAAEMMYHLFEFN-ZVGUSBNCSA-M sodium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate Chemical compound [Na+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O NKAAEMMYHLFEFN-ZVGUSBNCSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000001020 α-tocopherol group Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9214851A FR2698788B1 (fr) | 1992-12-09 | 1992-12-09 | Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ141995A3 CZ141995A3 (en) | 1995-10-18 |
| CZ289304B6 true CZ289304B6 (cs) | 2001-12-12 |
Family
ID=9436398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ19951419A CZ289304B6 (cs) | 1992-12-09 | 1993-12-09 | Farmaceutický prostředek ve formě efervescentních práąků nebo tablet, farmaceutický přípravek a způsob přípravy tohoto přípravku |
Country Status (26)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ300705B6 (cs) * | 1998-03-31 | 2009-07-22 | Meda Pharma Gmbh & Co. Kg | Šumivé formulace |
| CZ300704B6 (cs) * | 1998-03-31 | 2009-07-22 | Meda Pharma Gmbh & Co. Kg | Pevné, rychle se rozpadající formulace cetirizinu |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19502789A1 (de) * | 1995-01-28 | 1996-08-01 | Dirk Krischenowski | Arzneimittel |
| US5639475A (en) * | 1995-02-03 | 1997-06-17 | Eurand America, Incorporated | Effervescent microcapsules |
| UA43402C2 (uk) | 1995-05-05 | 2001-12-17 | Ново Нордіск А/С | Фармацевтична композиція, що містить тіагабінгідрохлорид, та спосіб її одержання |
| DE19606151C2 (de) * | 1996-02-20 | 1999-05-12 | Losan Pharma Gmbh | Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben |
| US6534016B1 (en) | 1997-04-30 | 2003-03-18 | Richmond Cohen | Additive preparation and method of use thereof |
| US6225123B1 (en) | 1997-04-30 | 2001-05-01 | Becton Dickinson And Company | Additive preparation and method of use thereof |
| GB9721397D0 (en) * | 1997-10-09 | 1997-12-10 | Verdugt Bv | Anticaking agents |
| NZ333474A (en) * | 1998-01-02 | 1999-06-29 | Mcneil Ppc Inc | A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat |
| IT1301966B1 (it) | 1998-07-30 | 2000-07-20 | Zambon Spa | Composizioni farmaceutiche ad attivita' analgesica |
| DE19962251A1 (de) * | 1999-12-22 | 2001-09-06 | Hermes Fabrik Pharm Praeparate | Lutschtablette |
| AU2001260083A1 (en) | 2000-05-26 | 2001-12-03 | Dr. Reddy's Research Foundation | New pharmaceutical composition and the process for its preparation |
| AU2000249111A1 (en) * | 2000-05-30 | 2001-12-11 | Dr. Reddy's Research Foundation | New pharmaceutical composition and the process for its preparation |
| AR029538A1 (es) * | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
| EP2277503B1 (en) | 2002-03-06 | 2014-02-12 | EffRx Pharmaceuticals SA | Effervescent compositions comprising bisphosphonates |
| US7488496B2 (en) * | 2002-03-06 | 2009-02-10 | Christer Rosen | Effervescent compositions comprising bisphosphonates and methods related thereto |
| DE102006029233A1 (de) * | 2006-06-26 | 2007-12-27 | Liedtke, Rainer K., Dr. | Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika |
| EP1902708A1 (de) * | 2006-09-25 | 2008-03-26 | Losan Pharma GmbH | Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung |
| US8445545B2 (en) * | 2008-05-07 | 2013-05-21 | Nicholas DeSica | Pharmaceutical composition, method of preparation and methods of treating aches/pains |
| WO2012154994A2 (en) | 2011-05-10 | 2012-11-15 | The Regents Of The University Of Californa | A novel adenovirus isolated from titi monkeys |
| US10221218B2 (en) | 2011-05-10 | 2019-03-05 | The Regents Of The University Of California | Adenovirus isolated from titi monkeys |
| EP2809179A4 (en) | 2012-02-01 | 2015-11-18 | Intercontinental Great Brands Llc | TABLET FOR HYPOCALORIC BEVERAGE |
| JP5877778B2 (ja) * | 2012-05-28 | 2016-03-08 | 株式会社ホットアルバム炭酸泉タブレット | 錠剤の製造方法及び錠剤 |
| FR3060391A1 (fr) * | 2016-12-20 | 2018-06-22 | Promindus Sarl | Composition pharmaceutique anti douleur |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3440288C2 (de) * | 1984-11-05 | 1987-03-12 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung |
| GB8528195D0 (en) * | 1985-11-15 | 1985-12-18 | Boots Co Plc | Therapeutic compositions |
| CH677606A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1988-07-12 | 1991-06-14 | Aesculapius Pharma Sa | |
| DE3838431A1 (de) * | 1988-11-12 | 1990-05-17 | Bayer Ag | Ibuprofen-brausezubereitungen |
| US5032384A (en) * | 1989-01-27 | 1991-07-16 | Block Drug Company, Inc. | Compositions and method for the treatment of disease |
| DE3904674A1 (de) * | 1989-02-16 | 1990-08-23 | Cassella Ag | Verwendung einer wirkstoffkombination zur behandlung rheumatischer erkrankungen |
| US5178878A (en) * | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
| RU2043099C1 (ru) * | 1994-01-31 | 1995-09-10 | Анатолий Евгеньевич Добротворский | Фармацевтическая композиция в форме шипучих таблеток и способ ее получения |
-
1992
- 1992-12-09 FR FR9214851A patent/FR2698788B1/fr not_active Expired - Lifetime
-
1993
- 1993-02-08 US US08/014,530 patent/US5480652A/en not_active Expired - Lifetime
- 1993-12-09 KR KR1019950700227A patent/KR950702414A/ko not_active Ceased
- 1993-12-09 AU AU56536/94A patent/AU679200B2/en not_active Expired
- 1993-12-09 DK DK94902008.5T patent/DK0673245T3/da active
- 1993-12-09 EP EP94902008A patent/EP0673245B1/fr not_active Revoked
- 1993-12-09 GE GEAP19932632A patent/GEP19991686B/en unknown
- 1993-12-09 SK SK728-95A patent/SK281775B6/sk not_active IP Right Cessation
- 1993-12-09 RU RU95114402A patent/RU2134577C1/ru active
- 1993-12-09 CA CA002150945A patent/CA2150945C/fr not_active Expired - Lifetime
- 1993-12-09 UA UA94129149A patent/UA27058C2/uk unknown
- 1993-12-09 ES ES94902008T patent/ES2110212T3/es not_active Expired - Lifetime
- 1993-12-09 JP JP51386894A patent/JP3579421B2/ja not_active Expired - Lifetime
- 1993-12-09 AT AT94902008T patent/ATE158504T1/de not_active IP Right Cessation
- 1993-12-09 CZ CZ19951419A patent/CZ289304B6/cs not_active IP Right Cessation
- 1993-12-09 HU HU9501671A patent/HU220632B1/hu unknown
- 1993-12-09 DE DE69314186T patent/DE69314186T2/de not_active Revoked
- 1993-12-09 WO PCT/FR1993/001216 patent/WO1994013279A1/fr not_active Application Discontinuation
- 1993-12-09 TJ TJ96000407A patent/TJ253B/xx unknown
- 1993-12-09 NZ NZ258596A patent/NZ258596A/en not_active IP Right Cessation
- 1993-12-15 TW TW082110660A patent/TW280774B/zh not_active IP Right Cessation
-
1994
- 1994-11-21 FI FI945452A patent/FI111517B/fi not_active IP Right Cessation
- 1994-11-23 EE EE9400211A patent/EE03089B1/xx unknown
- 1994-12-22 MD MD95-0026A patent/MD872G2/ro active IP Right Grant
-
1995
- 1995-06-06 US US08/471,155 patent/US5567437A/en not_active Expired - Lifetime
-
1997
- 1997-10-28 LV LVP-97-214A patent/LV11984B/lv unknown
- 1997-12-10 GR GR970403286T patent/GR3025634T3/el unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ300705B6 (cs) * | 1998-03-31 | 2009-07-22 | Meda Pharma Gmbh & Co. Kg | Šumivé formulace |
| CZ300704B6 (cs) * | 1998-03-31 | 2009-07-22 | Meda Pharma Gmbh & Co. Kg | Pevné, rychle se rozpadající formulace cetirizinu |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ289304B6 (cs) | Farmaceutický prostředek ve formě efervescentních práąků nebo tablet, farmaceutický přípravek a způsob přípravy tohoto přípravku | |
| EP0361680B1 (en) | Morphine-containing composition | |
| EP0557065B1 (en) | Spheroid formulation | |
| CA1306686C (en) | Pharmaceutical composition containing ibuprofen | |
| EP0999843B1 (en) | Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use | |
| SK284551B6 (sk) | Farmaceutický prípravok vo forme šumivej tablety | |
| CA2827892A1 (en) | Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer | |
| US6190697B1 (en) | Effervescent formulation containing plant extract | |
| EP0159852A2 (en) | Directly compressible pharmaceutical compositions | |
| FI86799C (fi) | Foerfarande foer framstaellning av skumbara blandningar | |
| KR100351193B1 (ko) | 아세틸살리실산메토클로프라미드화합물로구성된활성성분을갖는산제제조용조성물 | |
| JP3195360B2 (ja) | チアガビン塩酸塩を含有する医薬組成物およびその製法 | |
| US4950653A (en) | Solid iodophor composition | |
| JP2891744B2 (ja) | パントテン酸カルシウム組成物およびその製造方法 | |
| CS217603B1 (en) | Method of preparing compositions for dissolving renal calculi | |
| JPH09502709A (ja) | エストロン誘導体及びカルシウム塩含有の経口、水溶性製薬組成物 | |
| CN1265595A (zh) | 含维生素d和钙的药物组合物,其制备方法和治疗应用 | |
| HK1027751B (en) | Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use | |
| BG63620B1 (bg) | Състав и метод за получаване на ефервесцентна лекарствена форма |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD00 | Pending as of 2000-06-30 in czech republic | ||
| MK4A | Patent expired |
Effective date: 20131209 |